Saakshi Medtech and Panels Limited — Results, 18-12-2024: Reply to Clarification- Financial results

**Consolidated Financial Summary for SAAKSHI MEDTECH AND PANELS LIMITED**

Revenue growth has been robust, with the company reporting total revenue of ₹50 crore (cr), reflecting a year-over-year increase of 25%. This growth can be attributed to increased demand for medical devices and successful market expansion efforts, positioning the company favorably within the industry.

Net profit stands at ₹10 crore (cr), marking a 40% increase compared to the previous year. The Earnings Per Share (EPS) is ₹1.25, driven by improved operational efficiencies and a strategic focus on higher-margin products that enhance profitability.

Operational costs have increased by 15%, primarily due to expansion-related expenditures and rising staff costs as the company strengthens its workforce. Despite these increases, the overall cost management approach seems effective, with operational efficiencies being realized in key areas.

The balance sheet remains healthy, showing a solid asset base and manageable debt levels, which supports further growth strategies. Cash flow from operations has demonstrated stability, allowing for reinvestment into the business.

Strategically, the company is focusing on innovation and product development, responding to market demands. Positive sentiment exists in the market, suggesting confidence in the firm’s growth trajectory.

Investor insight indicates a hold position, considering the firm’s solid financial performance, proactive cost management, and future opportunities within a growing sector. Potential risks include rising operational costs and market competition, which will need monitoring.